KC
RNAM

Kryger Capital’s Avidity Biosciences RNAM Stock Holding History

Kryger Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,045,320
Closed -$75.4M – 84
2025
Q4 		$75.4M Buy
+1,045,320
New +$67.5M 5.82% 7

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Kryger Capital's RNAM Position: Q1 2026 in Review

Kryger Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,045,320 shares — an estimated $75.4M sold.

Kryger Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $75.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Kryger Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Kryger Capital sold 1,045,320 Avidity Biosciences shares in Q1 2026, an estimated $75.4M.
  • Kryger Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Kryger Capital's Avidity Biosciences position peaked at $75.4M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Kryger Capital's 13F filing for Q1 2026, filed 14 May 2026.